New Diagnostic System for Kidney Transplant Biopsies
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
Recruiting
Observational Study
Validation Study of Molecular Diagnostic System
Development of Reporting System for Molecular Diagnosis
Incorporate Molecular Diagnosis Into Diagnostic Standards
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- University of Alberta · Other
Who this trial is looking for
This trial is looking for kidney transplant recipients over 18 years old who are having a biopsy. Participants will help test a new system designed to improve diagnosis and treatment based on their biopsy results.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I am a kidney transplant recipient.
- My doctor has ordered a kidney biopsy for clinical reasons.
You may not be able to join if
- I do not want to take part in the study.
- I cannot give informed consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The current standard for biopsy-based diagnoses of dysfunction of kidney transplants is the Banff Classification which represents arbitrary international consensus. Recent data-driven approaches using molecular and conventional technologies indicate that mere consensus produces frequently incorrect diagnoses with potential harm to patients due to inappropriate treatment. To address this unmet need…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All kidney transplant recipients ≥18yrs of age undergoing a kidney biopsy for clinical indications, as determined by their physician or surgeon, will be eligible to enrol in the study.
Exclusion Criteria:
* Patients will be excluded from the study if they decline participati…
Contacts